140 related articles for article (PubMed ID: 17663751)
1. Paradoxical modulation of short-term facilitation of dopamine release by dopamine autoreceptors.
Kita JM; Parker LE; Phillips PE; Garris PA; Wightman RM
J Neurochem; 2007 Aug; 102(4):1115-24. PubMed ID: 17663751
[TBL] [Abstract][Full Text] [Related]
2. Heteromeric nicotinic acetylcholine-dopamine autoreceptor complexes modulate striatal dopamine release.
Quarta D; Ciruela F; Patkar K; Borycz J; Solinas M; Lluis C; Franco R; Wise RA; Goldberg SR; Hope BT; Woods AS; Ferré S
Neuropsychopharmacology; 2007 Jan; 32(1):35-42. PubMed ID: 16710311
[TBL] [Abstract][Full Text] [Related]
3. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.
Yoshida ST; Baella SA; Stuebner NM; Crawford CA; McDougall SA
Brain Res; 2006 Feb; 1073-1074():269-75. PubMed ID: 16427034
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of central and peripheral dopamine receptor activation on evoked firing in the trigeminocervical complex.
Charbit AR; Akerman S; Goadsby PJ
J Pharmacol Exp Ther; 2009 Nov; 331(2):752-63. PubMed ID: 19657051
[TBL] [Abstract][Full Text] [Related]
5. Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.
Marti M; Manzalini M; Fantin M; Bianchi C; Della Corte L; Morari M
J Neurochem; 2005 Apr; 93(1):195-205. PubMed ID: 15773919
[TBL] [Abstract][Full Text] [Related]
6. D2-like dopamine receptors modulate SKCa channel function in subthalamic nucleus neurons through inhibition of Cav2.2 channels.
Ramanathan S; Tkatch T; Atherton JF; Wilson CJ; Bevan MD
J Neurophysiol; 2008 Feb; 99(2):442-59. PubMed ID: 18094105
[TBL] [Abstract][Full Text] [Related]
7. [Chronic treatment with nicotine enhances the sensitivity of dopamine autoreceptors that modulate dopamine release from the rat striatum].
Takaki T
Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Aug; 15(4):335-44. PubMed ID: 7584728
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling.
Jordan S; Johnson JL; Regardie K; Chen R; Koprivica V; Tadori Y; Kambayashi J; Kitagawa H; Kikuchi T
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):348-56. PubMed ID: 17070976
[TBL] [Abstract][Full Text] [Related]
9. D2-like but not D1-like dopamine receptors are involved in the ventrolateral orbital cortex-induced antinociception: a GABAergic modulation mechanism.
Sheng HY; Qu CL; Huo FQ; Du JQ; Tang JS
Exp Neurol; 2009 Jan; 215(1):128-34. PubMed ID: 18952080
[TBL] [Abstract][Full Text] [Related]
10. Striatal dopamine D2 receptors attenuate neuropathic hypersensitivity in the rat.
Ansah OB; Leite-Almeida H; Wei H; Pertovaara A
Exp Neurol; 2007 Jun; 205(2):536-46. PubMed ID: 17451685
[TBL] [Abstract][Full Text] [Related]
11. Spatial reference- (not working- or procedural-) memory performance of aged rats in the water maze predicts the magnitude of sulpiride-induced facilitation of acetylcholine release by striatal slices.
Cassel JC; Lazaris A; Birthelmer A; Jackisch R
Neurobiol Aging; 2007 Aug; 28(8):1270-85. PubMed ID: 16843572
[TBL] [Abstract][Full Text] [Related]
12. Pre-synaptic nicotinic and D receptors functionally interact on dopaminergic nerve endings of rat and mouse nucleus accumbens.
Grilli M; Zappettini S; Zoli M; Marchi M
J Neurochem; 2009 Mar; 108(6):1507-14. PubMed ID: 19166510
[TBL] [Abstract][Full Text] [Related]
13. Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis.
Marcellino D; Carriba P; Filip M; Borgkvist A; Frankowska M; Bellido I; Tanganelli S; Müller CE; Fisone G; Lluis C; Agnati LF; Franco R; Fuxe K
Neuropharmacology; 2008 Apr; 54(5):815-23. PubMed ID: 18262573
[TBL] [Abstract][Full Text] [Related]
14. Lack of D2 receptor mediated regulation of dopamine synthesis in A11 diencephalospinal neurons in male and female mice.
Pappas SS; Behrouz B; Janis KL; Goudreau JL; Lookingland KJ
Brain Res; 2008 Jun; 1214():1-10. PubMed ID: 18462709
[TBL] [Abstract][Full Text] [Related]
15. Ontogenetic quinpirole treatment produces long-lasting decreases in the expression of Rgs9, but increases Rgs17 in the striatum, nucleus accumbens and frontal cortex.
Maple AM; Perna MK; Parlaman JP; Stanwood GD; Brown RW
Eur J Neurosci; 2007 Nov; 26(9):2532-8. PubMed ID: 17970732
[TBL] [Abstract][Full Text] [Related]
16. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo.
Millan MJ; Svenningsson P; Ashby CR; Hill M; Egeland M; Dekeyne A; Brocco M; Di Cara B; Lejeune F; Thomasson N; Munoz C; Mocaër E; Crossman A; Cistarelli L; Girardon S; Iob L; Veiga S; Gobert A
J Pharmacol Exp Ther; 2008 Feb; 324(2):600-11. PubMed ID: 18024787
[TBL] [Abstract][Full Text] [Related]
17. Effect of quinpirole on striatal dopamine release and locomotor activity in nicotine-treated mice.
Tammimäki A; Pietilä K; Raattamaa H; Ahtee L
Eur J Pharmacol; 2006 Feb; 531(1-3):118-25. PubMed ID: 16442094
[TBL] [Abstract][Full Text] [Related]
18. Presynaptic action of neurotensin on dopamine release through inhibition of D(2) receptor function.
Fawaz CS; Martel P; Leo D; Trudeau LE
BMC Neurosci; 2009 Aug; 10():96. PubMed ID: 19682375
[TBL] [Abstract][Full Text] [Related]
19. In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system.
Galineau L; Wilson AA; Garcia A; Houle S; Kapur S; Ginovart N
Synapse; 2006 Aug; 60(2):172-83. PubMed ID: 16715499
[TBL] [Abstract][Full Text] [Related]
20. Agonist and antagonist effects of aripiprazole on D₂-like receptors controlling rat brain dopamine synthesis depend on the dopaminergic tone.
Ma GF; Raivio N; Sabrià J; Ortiz J
Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
